Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Key clinical trials of moxetumomab pasudotox
| Drug(s) | Indication | Phase | Status | Location(s) | Identifier | |
|---|---|---|---|---|---|---|
| Moxetumomab pasudotox | Advanced HCL | 3 | Ongoing (not recruiting) | Multinational | NCT01829711; 130106; 13-C-0106; CD-ON-CAT-8015-1053 | MedImmune LLC |
| Moxetumomab pasudotox | R/R HCL | EAP | Ongoing | NA | NCT03501615; D3143R00002; MOXE | AstraZeneca |
| Moxetumomab pasudotox | HCL | 1 | Completed | Poland, USA | NCT00586924; CAT-8015-1001 | MedImmune LLC, Cambridge Antibody Technology |
EAP early access programme, NA not available
